Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results

May 9, 2023

https://www.globenewswire.com/news-release/2023/05/08/2663918/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Announces-First-Quarter-2023-Financial-Results.html

First patient dosed in Quoin’s single arm, open label clinical trial in Netherton Syndrome patients currently receiving off-label systemic therapy

Recruitment and dosing continue in Quoin’s ongoing double blinded, placebo-controlled study of QRX003 for Netherton Syndrome

Read more at globenewswire.com

Related news for (QNRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.